NAD+ and Sirtuins: A Beginner's Guide to the Longevity Research Everyone's Talking About

Have you ever wondered why some people seem to age faster than others at a cellular level? A big part of the answer comes down to a molecule called NAD+. Let me show you why researchers are so excited about it — and why it matters for how we age.

What is NAD+ and why does it matter?

Think of NAD+ as a rechargeable battery that powers your cells. Every cell in your body depends on it to produce energy, repair damaged DNA, and keep essential proteins functioning. Without enough of it, these processes slow down.

Here is the part researchers find most interesting: NAD+ levels decline with age across multiple tissues and organ systems. And when NAD+ drops, a whole chain of cellular processes starts to falter with it.

Enter the sirtuins

Sirtuins are a family of proteins that scientists have linked to how cells age. There are seven of them (SIRT1 through SIRT7), and they do important jobs — regulating how cells respond to stress, managing inflammation, and helping mitochondria (your cells' power generators) stay healthy.

The catch? Sirtuins require NAD+ to function. The biochemical connection between NAD+ levels and sirtuin activity is direct and well-established.

Less NAD+ means less sirtuin activity. Less sirtuin activity means the cellular maintenance systems they run start to underperform. This is the core idea driving most longevity research in this space.

Why does NAD+ fall as we age?

Two main culprits show up repeatedly in the research:

PARP enzymes. Every time your DNA gets damaged — which happens constantly from normal cellular activity — proteins called PARPs rush in to repair it. PARPs use NAD+ as fuel. PARP activity significantly increases with age, meaning a faster drain on the NAD+ pool.

CD38. This is an enzyme that breaks down NAD+ as part of normal cellular signaling. The problem is that CD38 levels rise with age and inflammation, consuming more NAD+ than younger cells would lose.

The result is a competition: sirtuins, PARPs, and CD38 are all drawing from the same shrinking pool. Sirtuins tend to lose that competition as we get older.

NAD+ Consumer	Role	What happens with age
Sirtuins	Cell maintenance, stress response, mitochondrial health	Activity slows as NAD+ declines
PARPs	DNA damage repair	Activity increases, consuming more NAD+
CD38	Cellular signaling	Levels rise with age and inflammation

What do sirtuins actually do when they are working well?

In laboratory research, active sirtuins have been linked to several downstream processes that longevity researchers pay close attention to:

Mitochondrial health. NAD+ activates SIRT1, which activates AMPK, which activates PGC-1α — a master regulator of mitochondrial biogenesis. In plain terms: an active sirtuin chain helps cells build and maintain healthier mitochondria.

Stress resistance. Sirtuins activate proteins called FOXO transcription factors, which help cells manage oxidative stress and activate cellular repair mechanisms.

Inflammation regulation. SIRT1 has been shown in research models to modulate NF-κB, a key driver of inflammatory signaling. Reduced sirtuin activity has been associated with increased inflammatory pathway activity in aged tissue.

What about NMN and NR?

You may have seen these two compounds mentioned alongside NAD+ research. Both are precursor molecules — meaning the body can convert them into NAD+ through what is called the salvage pathway.

NMN and NR have been the subject of significant research interest precisely because NAD+ itself cannot easily be delivered directly to cells. Giving the cell a building block and letting it assemble NAD+ is the approach most researchers have focused on.

Clinical trials consistently show that NAD+ precursors are absorbed and raise NAD+ levels in humans. Whether that translates into measurable downstream effects on aging biology is still being studied — but the foundational mechanism is well-supported.

What does the current research actually say?

The honest answer is: the science is promising but still developing.

The animal model data is strong. Restoring NAD+ prevented age-associated metabolic decline and promoted longevity in worm models, with effects dependent on sirtuin activity and involving activation of stress-response pathways inside mitochondria.

Human clinical data is catching up. A 2026 systematic review analyzing 80 rodent studies and 33 human studies found that while biological activity is clear, clinical effectiveness for anti-aging in humans remains inconclusive.

That is not a reason to dismiss the research — it is a reason to keep watching it closely. The NAD+/sirtuin axis is one of the most actively studied areas in aging biology, and new findings are coming out regularly.

The takeaway

NAD+ is not a magic molecule — but it is a genuinely important one. It sits at the center of energy production, DNA repair, and sirtuin signaling. Its decline with age is well-documented. And the research exploring what happens when you restore it is some of the most interesting science being done in the longevity field right now.

For anyone curious about the biology of aging at a cellular level, this is the pathway worth understanding first.

Want to explore the peptides that work alongside NAD+ in longevity research? Check out MOTS-c and Epitalon in our peptide library, or ask our AI assistant any question you have.

All content on PeptideTrainings.com is for educational reference only. Nothing here constitutes medical advice. Research compounds referenced are sold for laboratory research use only.